doi: 10.1186/s12891-022-05396-5 Summary Keywords type 2 diabetes, osteoporosis, GLP-1 receptor agonists, electronic medical records, cohort study, bone metabolism, fracture risk Citation Chen M, Lyu Y, Zhao J, Han X, Huang T, Yang T and Zhou Y (2025) Use of GLP-1 receptor agonist and risk of osteoporosis among patients with type 2 diabetes: a real-world study
The 2025 review also reported that in a large retrospective study of 461,328 adults initiating GLP-1 therapy, over 22% developed at least one nutritional deficiency within 12 months, with vitamin D the most common deficiency identified
Its multiple effects include: mediates chronic systemic inflammation that may contribute to increased atherosclerosis & premature CV mortality that associated with RA (Deeks, 2013)
Research consistently shows the combination outperforms either peptide alone: 3050% faster healing, reduced inflammation without the side effects of traditional drugs, stronger angiogenesis, less scar tissue, and improved functional recovery
Last year, two women were hospitalized in critical condition after being injected with peptides at a longevity conference in Las Vegas
Once your order has been dispatched, you will receive a dispatch notification containing your tracking details
&srotate=0)
